Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. - Wikidata - awgldk - TriplyDB

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

http://www.wikidata.org/entity/Q38396428

about

Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population Renal cell carcinoma in tuberous sclerosis complex.Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis Diagnostic approach to eosinophilic renal neoplasms Clinicopathological features of Xp11.2 translocation renal cell carcinoma.Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum Xp11.2 translocation renal cell carcinomas in young adults Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.Partial nephrectomy for the treatment of translocation renal cell carcinoma.Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing.Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.The utility of immunohistochemistry for providing genetic information on tumors.Biomarkers in renal cancer.RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas.Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement.Fine-needle aspiration findings of Xp11 translocation renal cell carcinoma metastatic to a hilar lymph node.TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma.Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma.Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press.Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis.Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO-TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum.Do significant TFE3 gene rearrangements occur in succinate dehydrogenase-deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution.Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH.Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report.MicroRNA expression profiling of Xp11 renal cell carcinoma.[The translocation carcinoma: A pediatric renal tumor also in adults].

P2860

Q26752945-0E872ECE-38B6-469C-BF33-502FB8CC1506 Q31046172-B51B9A2A-A35B-4A37-B755-80B35F9D8120 Q34070195-384A0DAE-BD19-486D-88C9-E53381427D3A Q35005701-13A69EC1-2F9D-41DF-985D-58FBD23F2A6A Q35155653-0B2EE98A-E05E-4368-AC9E-8FF1010F669A Q35164815-BED9DD22-11DD-46B4-A4D7-DDA6790A786E Q35636323-EA92A3F5-46C9-44CA-8DDC-0C4FA04B48F3 Q35678902-3E4C0CC6-A7BB-4238-8760-879BCEF632C4 Q35738410-2DF7562C-50CA-43F3-ABA9-A9C8B4792B25 Q36073126-5465F817-278E-4D1E-8C56-12A409350C82 Q36104776-A7457163-8A90-46BC-9AA0-BDE7A321E62D Q36151526-EAFA9935-E507-441B-A13D-E469EFEB7D4B Q36205571-C19599F0-06DE-47AE-AC77-8DF6C887788A Q36288139-9C7A456F-8B91-4CB3-A256-AC603CFF1EB0 Q37384169-BC2F4750-E18B-4E3F-A041-A149BDCB4A66 Q37623118-B690D62A-3CC0-418E-AAB2-67C5F4DE005B Q38142818-9EA01868-18B4-4EBE-8B1B-C1A111EAF04A Q38184386-58F4A53A-D7FD-4A8A-8D0F-28DED285DEB3 Q38375566-45001AB8-8E4B-4DF1-BA26-5B02BE41516A Q39010157-A7054AAB-8B9D-40FB-BD04-85F388EF9A1D Q39116265-0B487764-469A-4BB9-AA67-93F05784B543 Q39129490-A5517D83-6285-4CEA-B0A9-833F40E0EE77 Q39922019-2A0E57EE-6D7F-484A-B5FC-2B3D4D220745 Q40604025-6B02A72C-059B-4E78-A986-D9D536253735 Q41670942-BB219EDB-B8E3-4A91-8577-CA4A8E8B47AB Q42364326-F64BFDDB-8BE6-45FF-847A-F70FEA447340 Q42773286-D8BCE8C7-6F97-4BAE-81B2-81D99DF13130 Q42922556-2CC2E59C-27AC-45F1-8578-DD39932F42EB Q44136116-BE28C239-82FB-49F9-826C-33D352DB47D4 Q45066002-8191335A-2205-4CB2-802B-DF53AE444BDF Q46077309-4A23A74E-2117-44C7-B73D-E6ED4E741D8D Q46611738-A7CEE24A-0C3E-48DA-9612-6243BC794B1D Q47965589-002F25E7-4465-41FA-88C6-B9EABA8EF9CB Q48246775-55596944-0A9B-4646-92A7-5D94A8925B22 Q48252850-D5DC491C-89D4-4748-867F-566AD6FA98BB Q48284618-CEB4A98C-2524-4FDB-A999-30DD6A4C257E Q48289707-EE44256D-9537-4C9E-BAF4-1E7CEF1ACC33 Q49333917-42D34A48-04A7-4A49-8AE5-47A7A2745DDA Q50726690-78D00F06-00D8-4450-B811-BDA7AE3B1B0D Q53149212-E8219859-975B-4FA8-9B13-588A2D0F3F0E

P2860

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

http://www.wikidata.org/entity/Q38396428

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

@en

type

label

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

@en

prefLabel

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

@en

P1433

Q38396428-FAC8C0E1-B108-401C-A7C4-23E401CDDBDA

P1476

Q38396428-F0EA1CCE-8DCC-44A4-B1F4-EA9B8844B6AB

P2093

Q38396428-0D5312AC-BF71-490C-B66F-E4B3B8C43E37

Q38396428-1C833138-E198-45E1-8F51-6A8E281BA4A2

Q38396428-1C9DB1B6-B223-4861-BEDA-2359CF5818CD

Q38396428-3FC9DB26-7ADE-4391-9B65-82314A01F1F1

Q38396428-70685D3F-2872-42E8-993C-993C5CD43CB8

Q38396428-71207257-F2D5-4720-916C-EDB250868014

Q38396428-A3B0B18A-22FD-4FD0-940C-E26F46873C51

Q38396428-C3C2342E-8726-448C-86F3-EA4FCA706AD9

Q38396428-C4DDDB53-6A1C-4633-BEB0-F12693DCB4D2

Q38396428-D6241FC3-62A6-4B8D-B15E-009E500BC1DD

P304

Q38396428-BF6A94FE-A6A6-45B8-B629-1F29522F2549

P31

Q38396428-A6A54F26-13F1-4F23-8F01-769CCB644204

P356

Q38396428-42017336-6291-41B8-A119-24C4025E1A01

P407

Q38396428-01EF24BB-9546-496D-B2B4-DA537164F284

P433

Q38396428-A3E9A55E-1DA8-42D8-B54B-D6C862EE7247

P478

Q38396428-BA8B95C0-3BDE-4155-87F3-A43592AAF94D

P50

Q38396428-2B77BAE2-2D9C-41B3-A69F-F1146BFF621D

P577

Q38396428-2DB3A356-FFE3-482A-B549-D06CED5688EC

P698

Q38396428-0E255F95-36B5-488F-83CD-7CF38615BB7E

P356

PAS.0B013E31828A69AE

P1433

The American Journal of Surgical Pathology

P1476

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

@en

P2093

Constance A Griffin

http://www.w3.org/2001/XMLSchema#string

George J Netto

http://www.w3.org/2001/XMLSchema#string

Jonathan I Epstein

http://www.w3.org/2001/XMLSchema#string

Kerry Morris

http://www.w3.org/2001/XMLSchema#string

Laura Morsberger

http://www.w3.org/2001/XMLSchema#string

Mohamad Allaf

http://www.w3.org/2001/XMLSchema#string

Pedram Argani

http://www.w3.org/2001/XMLSchema#string

Peter B Illei

http://www.w3.org/2001/XMLSchema#string

Raluca Yonescu

http://www.w3.org/2001/XMLSchema#string

Whitney M Green

http://www.w3.org/2001/XMLSchema#string

P304

1150-1163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAS.0B013E31828A69AE

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23715164

http://www.w3.org/2001/XMLSchema#string